Core Viewpoint - The announcement details the extension of share pledges by the controlling shareholder and its concerted parties, indicating ongoing financial obligations and management of share voting rights [2][3][4]. Group 1: Shareholding and Pledge Details - The controlling shareholder, Shenzhen Jiadaocheng Investment Enterprise (Limited Partnership), and its concerted parties hold a total of 107,492,672 shares, representing 25.54% of the company's total shares [2]. - Tianjin Deyuan Health Management Co., Ltd. has pledged 56,787,503 shares, which is 47.52% of their total holdings and 12.14% of the company's total shares [2][3]. - The pledged shares include 32,723,260 shares for which voting rights have been irrevocably entrusted to the controlling shareholder, Jiadaocheng [3][4]. Group 2: Reasons for Pledge Extension - The extension of the share pledge is due to Tianjin Deyuan Health's inability to repay financing debts by the deadline, necessitating continued pledge of the shares [3]. - The company has indicated that Deyuan Health has the financial capability to repay, with funds sourced from operational income, asset disposals, and investment returns [4]. Group 3: Risk Management and Future Actions - The company asserts that the risks associated with the pledges are manageable, and Deyuan Health will take proactive measures if any related risks arise [7].
中源协和细胞基因工程股份有限公司关于控股股东一致行动人部分股权质押延期的公告